DanteVision Selected for the MSS Industry-Academia-Research Collabo R&D Program

DanteVision has been selected for the 2026 Industry-Academia-Research Collabo R&D program (commercialization track) of Korea's Ministry of SMEs and Startups.

As part of a consortium with NeuroBB, Gachon University, and Yonsei University, the project aims to build the preclinical foundation for an oral Alzheimer's disease drug candidate. DanteVision leads a sub-project together with Yonsei University, focusing on AI-based biomarker discovery and mechanism-of-action validation.

Project period: April 2026 – March 2028

Building on our 2025 preliminary study, we look forward to contributing our data analytics expertise to drug development.